A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial).

[1]  F. Sterz,et al.  Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment , 2003, Journal of internal medicine.

[2]  J. Singer,et al.  Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. , 2002, The New England journal of medicine.

[3]  H F Oxer,et al.  Outcomes of out-of-hospital cardiac arrest patients in Perth, Western Australia, 1996-1999. , 2001, Resuscitation.

[4]  M. Baubin,et al.  Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. , 2001, Resuscitation.

[5]  C. Bode,et al.  Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial , 2001, The Lancet.

[6]  M. Ruiz-Bailén,et al.  Role of thrombolysis in cardiac arrest , 2001, Intensive Care Medicine.

[7]  C. Callaway,et al.  Cardiac arrest and the role of thrombolytic agents. , 2000, Annals of emergency medicine.

[8]  D. Fatovich,et al.  Magnesium in cardiac arrest (the magic trial). , 1997, Resuscitation.

[9]  S. Gando,et al.  Massive Fibrin Formation with Consecutive Impairment of Fibrinolysis in Patients with Out-of-Hospital Cardiac Arrest , 1997, Thrombosis and Haemostasis.

[10]  R. Capone,et al.  Unsuccessful emergency medical resuscitation--are continued efforts in the emergency department justified? , 1991, The New England journal of medicine.

[11]  R O Cummins,et al.  Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. , 1991, Annals of emergency medicine.

[12]  R. Stanford,et al.  The National Health and Medical Research Council , 1937 .